Interestingly, Calebin A alone or in combinational treatment with TNF-β is capable of significantly suppressing p65-NF-κB expression time-dependently in all three CRC cell lines (Figure 4A,C). The gene discussed is NFKB1; the disease is colorectal carcinoma.